Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio

Sawai Selected for FTSE4Good and FTSE Blossom Japan Indexes

Osaka, Japan – July 23, 2019 – Sawai Pharmaceutical Co., Ltd. (Sawai, Head office: Osaka, Japan, President: Mitsuo Sawai) is pleased to announce that for the first time, it has been selected for the leading ESG (Environmental, Social, and Governance) indexes: FTSE4Good Index Series and FTSE Blossom Japan Index.

The FTSE4Good Global Index is published by FTSE Russell, an investment index calculator wholly owned by the London Stock Exchange. The index consists of companies that demonstrate strong ESG practices, and the FTSE Blossom Japan Index consists of Japanese companies that demonstrate strong ESG practices.

Sawai is now included in all three of the indexes used by Japan’s Government Pension Investment Fund (GPIF), one of the world’s largest pension funds: FTSE Blossom Japan Index, MSCI Japan Empowering Women Index (WIN), and S&P/JPX Carbon Efficient Index.

Sawai understands that “the business activities of Sawai Pharmaceutical itself are its contributions to society.” The company will continue to make contributions toward the realization of a sustainable society through its business activities or through its business processes.

Contact information:
PR / IR Group, Corporate Strategy Department, Sawai Pharmaceutical Co., Ltd
E-mail, koho@sawai.co.jp

Download Press Release

Careers

Join Our Team!

We’re hiring

Search Our Jobs

Close